Drugs Made In America Acquisition II Corp.

Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) is a blank-check company focused on the domestic pharmaceutical and drug manufacturing sector, reflecting the growing policy and investor interest in onshoring U.S. drug supply chains. The "II" designation marks this as the second SPAC vehicle from the same sponsor group, indicating a serial sponsor with prior experience in the space. The company filed a 10-Q with the SEC on May 14, 2026, under accession number 0001213900-26-056651, indicating it remains in its active search phase for a business combination target. Units continue to trade under the DMIIU ticker. For complete filing history, deal timelines, and sponsor profiles on DMIIU, sign up for full data access at SpacDesk.